AB Science S.A. (EPA:AB)
1.396
-0.008 (-0.57%)
Feb 2, 2026, 11:44 AM CET
AB Science Employees
AB Science had 36 employees as of June 30, 2025. The number of employees decreased by 3 or -7.69% since the number was reported on December 31, 2024.
Employees
36
Change
-3
Growth
-7.69%
Revenue / Employee
€28,528
Profits / Employee
€237,194
Market Cap
102.42M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 36 | -3 | -7.69% | 36 | 0 |
| Dec 31, 2024 | 39 | -18 | -31.58% | 28 | 11 |
| Dec 31, 2023 | 57 | -46 | -44.66% | 51 | 6 |
| Dec 31, 2022 | 103 | 5 | 5.10% | 103 | 0 |
| Dec 31, 2021 | 98 | 6 | 6.52% | 98 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 200,076 |
| Sanofi | 82,878 |
| Eurofins Scientific SE | 65,000 |
| Sartorius Stedim Biotech | 10,134 |
| Eurofins-Cerep | 207 |
| Crossject Société Anonyme | 103 |
| Adocia | 77 |
| Sensorion | 68 |
AB Science News
- 11 days ago - Investor AB GAAP EPS of SEK 18.09, revenue of SEK 16.79B - Seeking Alpha
- 7 weeks ago - AllianceBernstein Holding L.P. Limited Partnership Units (AB) Presents at Goldman Sachs 2025 U.S. Financial Services Conference Transcript - Seeking Alpha
- 2 months ago - Bitcoin Rebounds To $93,000 As Ethereum, XRP, Dogecoin Rise 3% - Benzinga
- 2 months ago - Bitcoin Slips Below $102,000 As Ethereum, XRP, Dogecoin Drop Over 2% - Benzinga
- 3 months ago - Q3 2025 Fingerprint Cards AB Earnings Call Transcript - GuruFocus
- 3 months ago - The AI Boom: Bubble Or Bonanza? - Seeking Alpha
- 3 months ago - AB Science S.A. (ABSCF) Discusses Clinical Update on AB8939 Combined With Venetoclax for Refractory and Relapsed AML With Poor Genetics Transcript - Seeking Alpha
- 6 months ago - Market concentration is scary and it's all around AI, says AB's Jim Tierney - CNBC